# Krüppel-like factor 10 promotes the progression of breast cancer by activating canonical NF-κB signaling

**Authors:** Xue-Wei Jiang, Jing Liu, Mei-Rong Bao, Xiao-Yan Bai, Ran Tao

PMC · DOI: 10.1016/j.isci.2026.115015 · iScience · 2026-02-13

## TL;DR

This study shows that KLF10 promotes breast cancer by activating the NF-κB signaling pathway, leading to cancer cell growth and spread.

## Contribution

The paper reveals a new mechanism where KLF10 activates NF-κB by upregulating RELA and degrading IκBα.

## Key findings

- KLF10 promotes breast cancer proliferation and metastasis.
- KLF10 activates NF-κB by increasing RELA expression and degrading IκBα.
- NF-κB targets like TNF, VEGFA, and MMP9 are upregulated by KLF10.

## Abstract

The elevation of NF-κB activity is frequently found in more malignant cancer types; however, the cause of this activation has still been controversial. Here, we showed that KLF10 promoted breast cancer progression by activating the NF-κB cascade. Mechanistically, KLF10 transcriptionally upregulated RELA mRNA expression. ChIP assay further validated the binding of KLF10 to the RELA promoter. Additionally, by interacting with IκBα and promoting its proteasomal degradation, KLF10 facilitated the release and nuclear translocation of p65, thereby activating the NF-κB signaling. The phosphorylated p65 level was dramatically increased upon KLF10 overexpression. Several targets of NF-κB, including TNF, VEGFA, PLAU, MMP9, ICAM1, CCND1, and MYC, were also upregulated by KLF10. In vivo experiments confirmed that KLF10 promoted breast cancer metastasis, with its expression positively correlated with p65 and negatively correlated with IκBα. Overall, our study elucidates a previously unidentified mechanism driving breast cancer progression, wherein the NF-κB signaling is drastically activated.

•KLF10 promotes the proliferation and metastasis of breast cancer cells•NF-κB signaling is involved in KLF10-mediated cancer progression•KLF10 activates NF-κB by inducing RELA transcription and IκBα protein degradation

KLF10 promotes the proliferation and metastasis of breast cancer cells

NF-κB signaling is involved in KLF10-mediated cancer progression

KLF10 activates NF-κB by inducing RELA transcription and IκBα protein degradation

Biological sciences; Cancer

## Linked entities

- **Genes:** KLF10 (KLF transcription factor 10) [NCBI Gene 7071], RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970], NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792], RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970], TNF (tumor necrosis factor) [NCBI Gene 7124], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422], PLAU (plasminogen activator, urokinase) [NCBI Gene 5328], MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318], ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383], CCND1 (cyclin D1) [NCBI Gene 595], MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609]
- **Proteins:** KLF10 (KLF transcription factor 10), RELA (RELA proto-oncogene, NF-kB subunit), NFKBIA (NFKB inhibitor alpha), RELA (RELA proto-oncogene, NF-kB subunit)
- **Diseases:** breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, NR4A1 (nuclear receptor subfamily 4 group A member 1) [NCBI Gene 3164] {aka GFRP1, HMR, N10, NAK-1, NGFIB, NP10}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, PLAU (plasminogen activator, urokinase) [NCBI Gene 5328] {aka ATF, BDPLT5, QPD, UPA, URK, u-PA}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}, REL (REL proto-oncogene, NF-kB subunit) [NCBI Gene 5966] {aka C-Rel, HIVEN86A, IMD92}, Nfkbia (nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha) [NCBI Gene 18035] {aka Nfkbi}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, GLB1 (galactosidase beta 1) [NCBI Gene 2720] {aka EBP, ELNR1, MPS4B}, NFKB2 (nuclear factor kappa B subunit 2) [NCBI Gene 4791] {aka CVID10, H2TF1, LYT-10, LYT10, NF-kB2, p100}, KLF8 (KLF transcription factor 8) [NCBI Gene 11279] {aka BKLF3, ZNF741}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, KLF9 (KLF transcription factor 9) [NCBI Gene 687] {aka BTEB, BTEB1}, KLF10 (KLF transcription factor 10) [NCBI Gene 7071] {aka EGR-alpha, EGRA, TIEG, TIEG1}, KLF6 (KLF transcription factor 6) [NCBI Gene 1316] {aka BCD1, CBA1, COPEB, CPBP, GBF, PAC1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, KLF5 (KLF transcription factor 5) [NCBI Gene 688] {aka BTEB2, CKLF, IKLF}, CASC7 [NCBI Gene 286109], CCND1 (cyclin D1) [NCBI Gene 595] {aka BCL1, D11S287E, PRAD1, U21B31}, RELB (RELB proto-oncogene, NF-kB subunit) [NCBI Gene 5971] {aka I-REL, IMD53, IREL, REL-B}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, Klf10 (Kruppel-like transcription factor 10) [NCBI Gene 21847] {aka EGR[a], Egral, Gdnfif, TIEG-1, Tieg, Tieg1}, NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792] {aka EDAID2, IKBA, MAD-3, NFKBI}, Rela (Rela proto-oncogene, NFKB subunit) [NCBI Gene 19697] {aka p65, p65 NF-kappa B, p65 NFkB}
- **Diseases:** osteosarcoma (MESH:D012516), inflammation (MESH:D007249), Cancer (MESH:D009369), lung tumor (MESH:D008175), carcinogenesis (MESH:D063646), head and neck squamous cell carcinoma (MESH:D000077195), lung metastasis (MESH:D009362), breast oncogenesis (MESH:D061325), thyroid cancer (MESH:D013964), I-L (MESH:D007926), weight loss (MESH:D015431), Breast Invasive Carcinoma (MESH:D001943), triple-negative (MESH:D064726), hepatocellular carcinoma (MESH:D006528), glioblastoma (MESH:D005909)
- **Chemicals:** formazan (MESH:D005562), streptomycin (MESH:D013307), MG132 (MESH:C072553), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MESH:C022616), DMEM medium (-), penicillin (MESH:D010406), MTT (MESH:C070243), CO2 (MESH:D002245), agarose (MESH:D012685), DMSO (MESH:D004121)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** ZR-75-30 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_1661), /c — Mus musculus (Mouse), Hepatocellular carcinoma of the mouse, Cancer cell line (CVCL_9103), HEK 293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), 4T1 — Mus musculus (Mouse), Malignant neoplasms of the mouse mammary gland, Cancer cell line (CVCL_0125), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), BALB/c — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0184), 3E — Mus musculus (Mouse), Malignant neoplasms of the mouse mammary gland, Cancer cell line (CVCL_L873)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12964234/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12964234/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC12964234/full.md

---
Source: https://tomesphere.com/paper/PMC12964234